0001493152-23-034696.txt : 20230929 0001493152-23-034696.hdr.sgml : 20230929 20230928181704 ACCESSION NUMBER: 0001493152-23-034696 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230926 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230929 DATE AS OF CHANGE: 20230928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 231291258 BUSINESS ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 8-K 1 form8-k.htm
0001815974 false 0001815974 2023-09-26 2023-09-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 26, 2023

 

 

 

ANEBULO PHARMACEUTICALS, INC

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-40388   85-1170950

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

Anebulo Pharmaceuticals, Inc.

1017 Ranch Road 620 South, Suite 107

Lakeway, TX

  78734
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (512) 598-0931

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $.0.001 par value per share   ANEB   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 26, 2023, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), appointed Daniel George as the Company’s part-time Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer, effective September 28, 2023, replacing Sandra A. Gardiner in such capacities.

 

Daniel George, age 53, has managed his professional services practice since December 2022, specializing in providing executive financial services to healthcare companies. Mr. George served as the Chief Financial Officer and Treasurer of Lucira Health, Inc. a publicly traded medical diagnostics company on a full-time basis from August 2020 to November 2022. From April 2019 until August 2020, Mr. George served as Lucira’s Chief Financial Officer and Treasurer through his consulting practice, which he established in May 2016, specializing in providing executive financial services to healthcare companies covering a broad range of specialties. Mr. George served as Vice President, Finance for Avinger Inc., a publicly traded medical device company specializing in peripheral atherectomy from August 2014 to May 2016. From June 2012 to August 2014, Mr. George served as a consultant and Vice President of Finance for ApniCure, Inc., a medical device company specializing in the treatment of sleep apnea. From March 2009 to June 2012, Mr. George worked for Avantis Medical Systems, Inc., a manufacturer of colonoscopy visualization technology, where he was both a consultant and Chief Financial Officer. Mr. George was also the Sr. Director of Finance at FoxHollow Technologies Inc., a publicly traded medical device company, and worked for PricewaterhouseCoopers LLP, an accounting and management consulting firm, in the assurance and business advisory practice. Mr. George holds B.S. degrees in both Accounting and Finance from California State University, Long Beach.

 

In connection with his appointment as the Company’s part-time Chief Financial Officer, on September 26, 2023, the Company entered into an offer letter with Mr. George, which provides for compensation at a rate of $400 per hour.

 

The foregoing summary of the offer letter with Mr. George is not complete and is qualified in its entirety by reference to the full agreement, a copy of which is filed as Exhibit 10.1 to this report.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit

Number

  Description
10.1   Offer Letter, effective September 26, 2023, between the Company and Daniel George.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ANEBULO PHARMACEUTICALS, INC.
     
Date: September 28, 2023 By: /s/ Simon Allen
    Simon Allen
    Chief Executive Officer (Principal Executive Officer)

 

 

 

EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

 

 

September 25, 2023

 

Daniel George

16630 Glenn Canyon Ct.

Morgan Hill, CA 95037

 

Re: Employment Terms

 

Dear Daniel:

 

Anebulo Pharmaceuticals, Inc. (the “Company”) is pleased to offer you employment beginning on September 28, 2023 (the “Start Date”).

 

Position

 

Your initial position will be Chief Financial Officer, responsible for performing such duties as are assigned to you from time to time, reporting to the Chief Executive Officer of the Company. You will work remotely from your home in Morgan Hill, California. Your position will be hourly part-time, with a typical work schedule of up to 10 hours per week. You will be scheduled according to the Company’s needs, and the Company does not guarantee you any minimum number of hours of work per week. Of course, the Company may change your position, duties, and work location from time to time in its discretion.

 

The Company acknowledges and agrees that you will be permitted to continue performing consulting services for other businesses, provided that such activities are not directly or indirectly competitive with the Company.

 

Compensation and Benefits

 

Your rate of pay will be $400 per hour, less payroll deductions and withholdings, paid on the Company’s normal payroll schedule. You must record your hours worked on a daily basis, including your start and stop times (including meal periods, if applicable).

 

As a part-time employee, under the terms of the Company’s benefits plan and policies, you will not be eligible for company benefits that are otherwise offered to regular full-time employees, except as required by applicable law.

 

Confidential Information and Company Policies

 

As a Company employee, you will be expected to abide by Company rules and policies. As a condition of employment, you must sign and comply with the attached Employee Confidential Information and Inventions Assignment Agreement which prohibits unauthorized use or disclosure of the Company’s proprietary information, among other obligations.

 

By signing this letter you are representing that you have full authority to accept this position and perform the duties of the position without conflict with any other obligations and that you are not involved in any situation that might create, or appear to create, a conflict of interest with respect to your loyalty or duties to the Company. You specifically warrant that you are not subject to an employment agreement or restrictive covenant preventing full performance of your duties to the Company. You agree not to bring to the Company or use in the performance of your responsibilities at the Company any materials or documents of a former employer that are not generally available to the public, unless you have obtained express written authorization from the former employer for their possession and use. You also agree to honor all obligations to former employers during your employment with the Company.

 

 

 

 

At-Will Employment

 

Your employment with the Company will be “at-will,” except where prohibited by state law. You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company. Likewise, the Company may terminate your employment at any time, with or without cause or advance notice. Your employment at-will status can only be modified in a written agreement signed by you and by a duly authorized officer of the Company.

 

Conditions, Dispute Resolution, and Complete Agreement

 

This offer is contingent upon a satisfactory reference check and satisfactory proof of your right to work in the United States. If the Company informs you that you are required to complete a background check, this offer is contingent upon satisfactory clearance of such background check. You agree to assist as needed and to complete any documentation at the Company’s request to meet these conditions.

 

To aid the rapid and economical resolution of disputes that may arise in connection with your employment with the Company, and in exchange for the mutual promises contained in this offer letter, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims arising from or relating to the enforcement, breach, performance, or interpretation of this letter agreement, your employment with the Company, or the termination of your employment, shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS, Inc. (“JAMS”) or its successor, under JAMS’ then applicable rules and procedures appropriate to the relief being sought (available upon request and also currently available at the following web address: (i) https://www.jamsadr.com/rules-employment-arbitration/) and (ii) https://www.jamsadr.com/rules-comprehensive-arbitration/) at a location closest to where you last worked for the Company or another mutually agreeable location. Notwithstanding the foregoing, if JAMS is unavailable due to location or otherwise, or if the parties mutually agree, then the arbitration shall be conducted by the American Arbitration Association (“AAA”) or its successor, under AAA’s then applicable rules and procedures appropriate to the relief being sought (available upon request and also currently available at the following web address: https://www.adr.org/sites/default/files/EmploymentRules-Web.pdf), at a location closest to where you last worked for the Company or another mutually agreeable location. You acknowledge that by agreeing to this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a trial by jury or judge. The Federal Arbitration Act, 9 U.S.C. § 1 et seq., will, to the fullest extent permitted by law, govern the interpretation and enforcement of this arbitration agreement and any arbitration proceedings. This provision shall not be mandatory for any claim or cause of action to the extent applicable law prohibits subjecting such claim or cause of action to mandatory arbitration and such applicable law is not preempted by the Federal Arbitration Act or otherwise invalid (collectively, the “Excluded Claims”), such as non-individual claims that cannot be waived under applicable law, claims or causes of action alleging sexual harassment or a nonconsensual sexual act or sexual contact, or unemployment or workers’ compensation claims brought before the applicable state governmental agency. In the event you or the Company intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration. You acknowledge and agree that proceedings of any non-individual claim(s) under the California Private Attorneys General Act (“PAGA”) that may be brought in court shall be stayed for the duration and pending a final resolution of the arbitration of any individual or individual PAGA claim. Nothing herein prevents you from filing and pursuing proceedings before a federal or state governmental agency, although if you choose to pursue a claim following the exhaustion of any applicable administrative remedies, that claim would be subject to this provision. In addition, with the exception of Excluded Claims arising out of 9 U.S.C. § 401 et seq., all claims, disputes, or causes of action under this section, whether by you or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class, representative, or collective proceeding, nor joined or consolidated with the claims of any other person or entity. You acknowledge that by agreeing to this arbitration procedure, both you and the Company waive all rights to have any dispute be brought, heard, administered, resolved, or arbitrated on a class, representative, or collective action basis. The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding. If a court finds, by means of a final decision, not subject to any further appeal or recourse, that the preceding sentences regarding class, representative, or collective claims or proceedings violate applicable law or are otherwise found unenforceable as to a particular claim or request for relief, the parties agree that any such claim(s) or request(s) for relief be severed from the arbitration and may proceed in a court of law rather than by arbitration. All other claims or requests for relief shall be arbitrated. You will have the right to be represented by legal counsel at any arbitration proceeding. Questions of whether a claim is subject to arbitration and procedural questions which grow out of the dispute and bear on the final disposition are matters for the arbitrator to decide, provided however, that if required by applicable law, a court and not the arbitrator may determine the enforceability of this paragraph with respect to Excluded Claims. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator’s essential findings and conclusions on which the award is based. The arbitrator shall be authorized to award all relief that you or the Company would be entitled to seek in a court of law. The Company shall pay all arbitration administrative fees in excess of the administrative fees that you would be required to pay if the dispute were decided in a court of law. Each party is responsible for its own attorneys’ fees, except as may be expressly set forth in your Employee Confidential Information and Inventions Assignment Agreement or as otherwise provided under applicable law. Nothing in this letter agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction.

 

  Page 2

 

 

This letter, together with your Employee Confidential Information and Inventions Assignment Agreement, forms the complete and exclusive statement of your employment agreement with the Company. It supersedes any other agreements or promises made to you by anyone, whether oral or written. You acknowledge and agree that you are not relying on any representations other than the terms set forth in this letter. Changes in your employment terms, other than those changes expressly reserved to the Company’s discretion in this letter, require a written modification signed by a duly authorized officer of the Company. If any provision of this offer letter agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this offer letter agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law. This letter may be delivered and executed via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and shall be deemed to have been duly and validly delivered and executed and be valid and effective for all purposes.

 

*         *         *

 

Please sign and date this letter and the enclosed Employee Confidential Information and Inventions Assignment Agreement and return them to me by September 27, 2023, if you wish to accept employment at the Company under the terms described above.

 

We look forward to your favorable reply and to a productive and enjoyable work relationship.

 

Sincerely,

 

/s/ Simon Allen    

Simon Allen, Chief Executive Officer

   
     
Understood and Accepted:    
     
/s/ Daniel George   9/26/23
Daniel George   Date
     
     
dgeorge@dvgsolutions.com    

 

Attachment: Employee Confidential Information and Inventions Assignment Agreement

 

  Page 3

 

GRAPHIC 3 ex10-1_001.jpg begin 644 ex10-1_001.jpg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aneb-20230926.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 aneb-20230926_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 aneb-20230926_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Sep. 26, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 26, 2023
Entity File Number 001-40388
Entity Registrant Name ANEBULO PHARMACEUTICALS, INC
Entity Central Index Key 0001815974
Entity Tax Identification Number 85-1170950
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One Anebulo Pharmaceuticals, Inc.
Entity Address, Address Line Two 1017 Ranch Road 620 South
Entity Address, Address Line Three Suite 107
Entity Address, City or Town Lakeway
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78734
City Area Code (512)
Local Phone Number 598-0931
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $.0.001 par value per share
Trading Symbol ANEB
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001815974 2023-09-26 2023-09-26 iso4217:USD shares iso4217:USD shares 0001815974 false 8-K 2023-09-26 ANEBULO PHARMACEUTICALS, INC DE 001-40388 85-1170950 Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South Suite 107 Lakeway TX 78734 (512) 598-0931 false false false false Common Stock, $.0.001 par value per share ANEB NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 25 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://anebulo.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aneb-20230926.xsd aneb-20230926_lab.xml aneb-20230926_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "ANEB", "nsuri": "http://anebulo.com/20230926", "dts": { "schema": { "local": [ "aneb-20230926.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "aneb-20230926_lab.xml" ] }, "presentationLink": { "local": [ "aneb-20230926_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://anebulo.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-09-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://anebulo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-23-034696-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-034696-xbrl.zip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end